We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Requests Analyses, Inspection Fixes in CRL for Tumor Therapy
FDA Requests Analyses, Inspection Fixes in CRL for Tumor Therapy
The FDA has rejected Advanced Accelerator Applications’ candidate for the treatment neuroendocrine tumors in adults, requesting that the company submit new analyses and correct manufacturing deficiencies.